Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Disease Markers|May 1, 1991
Antibody directed enzyme prodrug therapy (ADEPT): a three phase systemS K Sharma, K D Bagshawe, C J Springer, et al.Cell Biophysics|January 1, 1993
Antitumor effects of an antibody-carboxypeptidase G2 conjugate in combination with a benzoic acid mustard prodrugD C Blakey, B E Valcaccia, S East, et al.British Journal of Cancer|November 1, 1995
Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugsD C Blakey, D H Davies, R I Dowell, et al.Gene Therapy|December 1, 1996
Investigation of alternative prodrugs for use with E. coli nitroreductase in 'suicide gene' approaches to cancer therapyS M Bailey, R J Knox, S M Hobbs, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compoundsC J Springer, K D Bagshawe, S K Sharma, et al.Immunotechnology : an International Journal of Immunological Engineering|February 1, 1996
In vitro and in vivo characterisation of a recombinant carboxypeptidase G2::anti-CEA scFv fusion proteinN P Michael, K A Chester, R G Melton, et al.Journal of Medicinal Chemistry|March 1, 1996
New mustard prodrugs for antibody-directed enzyme prodrug therapy: alternatives to the amide linkR I Dowell, C J Springer, D H Davies, et al.Cancer Gene Therapy|July 1, 1997
Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by retroviral transduction and expression of the E. coli nitroreductase geneN K Green, D J Youngs, J P Neoptolemos, et al.Cancer Research|July 15, 1996
ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumor regressions in colorectal tumor xenograftsD C Blakey, P J Burke, D H Davies, et al.Pageof 4